The combination of thalidomide, cyclophosphamide and dexamethasone is potentially useful in highly resistant Hodgkin's lymphoma

  1. García-Sanz, R.
  2. González-López, T.J.
  3. Vázquez, L.
  4. Hermida, G.
  5. Graciani, I.F.
  6. San Miguel, J.F.
Aldizkaria:
European Journal of Haematology

ISSN: 0902-4441,  1600-0609

Argitalpen urtea: 2010

Alea: 84

Zenbakia: 3

Orrialdeak: 266-270

Mota: Artikulua

DOI: 10.1111/J.1600-0609.2009.01375.X GOOGLE SCHOLAR
Datuen iturria: Scopus